Power3 Medical Products, Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical Products, Inc. applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical Products, Inc. has developed a portfolio of products including NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

About 1 in 8 women in the United States (12%) will develop invasive breast cancer over the course of her lifetime. In 2010, an estimated 207,090 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S., along with 54,010 new cases of non-invasive (in situ) breast cancer. About 1,970 new cases of invasive breast cancer were expected to be diagnosed in men in 2010. Less than 1% of all new breast cancer cases occur in men.

When the breast cancer cells spreads commencing the lymph nodes, they cause ruthless wound to additional parts of the body. The a large amount conventional parts are brain, liver, lungs and bones. The new to the job lump fashioned clothed in the additional carve up contains similar characteristics of initial one. representing examples proviso the breast cancer is spreads to the liver at that moment the cancer is termed as metastatic breast cancer except not as liver cancer.

BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminates function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

For more information, please visit their website: http://www.power3medical.com

*************************************************************

Envoy Capital Group, Inc. (Nasdaq:ECGI) released its financial results for the second quarter of fiscal 2011. For the quarter ended March 31, 2011, Envoy incurred a net loss of ($6.4) million or ($0.80) per fully diluted share compared with a net income of $0.9 million or $0.11 per fully diluted share for the same quarter last year. Included in the results for the current quarter is approximately $6.1 million in one-time restructuring costs. The per-share calculations are based on fully diluted, weighted average shares outstanding of approximately 8.0 million for the current quarter and 8.4 million for the prior year.

Envoy Capital Group Inc., through its subsidiary, Watt International Inc., operates as a consumer and retail branding company. It offers consulting, branding, packaging, and retail design services to clients in Canada, the United States, Mexico, the United Arab Emirates, China, and South America, as well as project work for clients in other countries.

*************************************************************

Recon Technology, Ltd. (Nasdaq:RCON) announced its financial results for the third fiscal quarter ended March 31, 2011. Summary financial data is provided below; Revenues for the third quarter of fiscal year 2011 decreased by 57.74% year-over-year to $1.7 million, down from $4.0 million in the third quarter of fiscal 2010. Gross margin for the third quarter was 17.9% based on gross profit of $302 thousand, compared with a 44.7% margin based on gross profit of $1.8 million in the same period last year. Operating expenses for the third quarter were $1.5 million, up 97.7% year-over-year from $741 thousand in the same period last year. Operating loss for the third quarter was $1.2 million, down 211.18% compared to operating income of $1.0 million in the third quarter of fiscal 2010. Net loss attributable to Recon for the third quarter decreased 263.21% year-over-year to $1.1 million compared with net income of $689 thousand for the third quarter of fiscal 2010. Loss per diluted share was $0.28 for the quarter, down 263.21% from diluted EPS of $0.17 achieved in the same period a year ago.

Recon Technology, Ltd provides services designed to automate and enhance the extraction of petroleum in China. The company offers equipment, tools, and other hardware related to oilfield production and management; and develops and sells industrial specialized automation control and information solutions.

*************************************************************

Ener1, Inc. (Nasdaq:HEV) announced financial results for the first fiscal quarter of 2011 ending March 31, 2011. “We believe our first-quarter results represent another step forward in building a profitable business,” said Ener1 Chairman and CEO Charles Gassenheimer. Total consolidated revenue for the quarter was $23.1 million, an increase of 110% over the first quarter of 2010. Consolidated gross profit margin improved to 24%, compared to 10% in the year-ago quarter. Due primarily to an impairment charge, the company reported a net loss of $84.7 million, or diluted net loss per share of $0.51 for the quarter. The impairment charge represents a $69.4 million increase in net loss, which represents a one-time $59.4 million impairment recorded during the first quarter to write down the company’s investment in Think Holdings and a $13.9 million loss on financial instruments, which is primarily attributable to the impaired value of the investment. The impairment charge and loss on financial instruments totaled $73.3 million, or $0.44 per diluted share, for the three months ending March 31, 2011. This compares to a net loss of $15.3 million, or diluted net loss per share of $0.13, during the same period last year. Final testing began on two grid energy storage units for the Russian Federal Grid Company to be shipped in the next few weeks; Completion of delivery of nine batteries to Hyundai Heavy Industries by Ener1’s transportation group to power all-electric transit buses in Seoul and securing of an order for ten additional systems to be delivered in the third quarter; An increase in revenue by 12% and improved gross margin percentage of 22% over the same quarter last year by our small pack business, which provides lithium-ion battery solutions to companies like Motorola; A new president, Chris Cowger, formerly vice president and general manager of AMD’s global consumer software and peripherals division.

Ener1, Inc., together with its subsidiaries, engages in designing, developing, and manufacturing rechargeable lithium-ion batteries and battery systems for energy storage in the United States and South Korea.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

MusclePharm(R) Corporation (OTCBB:MSLP.OB), one of the fastest growing nutritional supplement companies in the United States, is pleased to announced a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.

The partnership begins in 2011 and MusclePharm will work closely with the WBFF and its President and CEO, Paul Dillett, who is widely considered one of the greatest bodybuilders in the sport’s history. Dillett, recognized as Canada’s greatest bodybuilder, won numerous bodybuilding titles throughout his illustrious career, and is often regarded as having one of the sport’s most recognizable physiques.

More:

MSLP announced a fulfillment agreement with IVitals that is expected to improve cash flow, reduce backorders, improve turnaround time on all orders and allow management to focus its time and resources on the marketing and selling of MusclePharm’s growing portfolio of products.

The Company expects to achieve over $4 million in sales for the full year of 2010, which is over 300% growth compared to the same period last year. The rapid growth and strong customer demand for the MusclePharm products has created back orders for 5 of the 12 months in 2010. The new fulfillment agreement is expect to greatly improve the back orders for the remainder of 2010 and reduce the insufficient levels of stock needed to complete all orders.

MSLP’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

More about MSLP at: www.musclepharm.com

**************************************************************

Quest Software, Inc. (Nasdaq:QSFT) announced it has won 38 different awards from MSExchange.org, Redmond Magazine, SQL Server Magazine, Windows IT Pro, and Visual Studio Magazine. Winning Quest products span the company’s SQL Server management, Windows management, identity management, virtualization management, desktop management and SharePoint management product portfolios. In total, 18 different Quest products raked in recognition, with ScriptLogic Active Administrator® , Quest Authentication Services, LiteSpeed® for SQL Server, PowerGUI® Pro, ScriptLogic Desktop Authority®, and Toad® for SQL Server receiving multiple awards.

Quest Software, Inc. designs, develops, markets, distributes, and supports enterprise systems management software products worldwide.

**************************************************************

American Superconductor Corporation (Nasdaq:AMSC) a global power technologies company, announced that Korea’s LS Cable Ltd. and France’s Nexans have been selected as the superconductor power cable subcontractors for the Tres Amigas SuperStation. This first-of-its-kind power transmission hub will be located in Clovis, New Mexico and is expected to link America’s three primary electric transmission grids – the Eastern (Southwest Power Pool), Western (Western Electricity Coordinating Council) and Texas (Electric Reliability Council of Texas) interconnections. LS Cable and Nexans will both manufacture superconductor power cables utilizing Amperium wire – AMSC’s proprietary second generation (2G) high temperature superconductor (HTS) wire.

American Superconductor Corporation, a power technologies company, provides wind turbine designs and electrical control systems primarily in North America, Europe, and the Asia-Pacific.

**************************************************************

Martin Midstream Partners LP (Nasdaq:MMLP) announced that the Partnership will participate and make an investor presentation at an upcoming master limited partnership conference. Ruben Martin, President and Chief Executive Officer of Martin Midstream GP LLC, MMLP’s general partner, and other members of senior management will present on Tuesday, December 7, 2010 at the Wells Fargo Securities 9th Annual Pipeline, MLP and Energy Symposium in New York City. MMLP will present from 11:35am to approximately 12:00pm Eastern Standard Time at the symposium.

Martin Midstream Partners L.P. engages in the collection, transportation, storage, and marketing of petroleum products and by-products in the United States Gulf Coast region.

**************************************************************

Orofino Gold Corp. (ORFG.PK) (”Orofino Gold” or the “Company”) has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.

The company newly announced that the Board Of Directors have appointed Mr. Ning Shi Long as Chairman of the Board and Executive Director.

Mr. Ary Fernando Pernett Marque has been appointed as the new President/CEO & Executive Director of Orofino Gold Corp. (see full resume on the company website at www.orofinogold.com)

Mr. Pernett will be responsible for all affairs of the Company in Colombia. Mr. Pernett has 30 years of experience working in the Colombian Mining sector and will over the near term choose his new development team to assist in the development of the company’s Senderos de Oro gold camp in the Sur de Bolivar Colombia.

The company and Mr. Pernett will continue to work with Contexto Legal of Medellin and Bogota, the company’s legal counsel as well as Discovery Consultants, (The Qualified 43-101 team) Canada, as they have in the past. The new team will now aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine.

The Board of Director’s have accepted resignation of John T. Martin, former Managing Director of the Company. His resignation is effective immediately. The Company wish him well and success in future endeavors.

Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. The company has an option to acquire properties in the Sur de Bolivar Department of Colombia South America. Orofino Gold Corp. was formerly known as SNT Cleaning, Inc. and changed its name to Orofino Gold Corp. in December 2009. The company was founded in 2005 and is based in Central, Hong Kong.

More about ORFG at:www.orofinogold.com

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.

Global Hunter Corp. (the “Company”) (TSX.V:BOB.V) engages in the acquisition, exploration, and development of mineral properties in Canada and Chile. It primarily explores for gold, copper, and base and precious metals. The company was founded in 1988 and is headquartered in Vancouver, Canada.

Global Hunter is pleased to announce that it recently completed a surface sampling program at La Corona de Cobre. The program was designed to collect surface samples from the numerous prospective shear zones. This will aid in the definition of drill targets to expand on the copper oxide mineralization. The company has collected approximately 250 samples from the shear zones listed below.

The shear zones and areas of alteration that have been sampled (from East to West) include the following zones:

- El Manto
- La Golondrina
- Cerro Borracho
- El Tazon
- La Copa
- La Varrilla
- Et Tazon
- Vino Fino
- Abisinia
- Las Posadas

The samples will be collected from outcrops along the entire strike lengths of the shears and have been shipped to ALS Chemex Labs in La Serena Chile for analysis. Results will be released as soon as is practical after they have been received.

More about (TSX.V:BOB) at: www.globalhunter.ca

**************************************************************

RGC Resources Inc. (Nasdaq:RGCO) declared a quarterly dividend of $0.34 per share on the Company’s common stock. The indicated annual dividend is $1.36 per share, a $0.04 per share increase over the prior level. The dividend will be paid on February 1, 2010 to shareholders of record on January 14, 2011. This is the Company’s 267th consecutive quarterly cash dividend.

RGC Resources, Inc., together with its subsidiaries, operates as an energy services company.

**************************************************************

Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month. The primary endpoint was statistical non-inferiority in the proportion of patients who maintained (or improved) vision over 52 weeks compared to ranibizumab. Further results will be presented at the Angiogenesis Conference in February 2011. Bayer HealthCare and Regeneron are planning to submit regulatory applications for marketing approval in Europe and the U.S. in the first-half of 2011 based on the positive results of the VIEW 1 and VIEW 2 trials.

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States.

a leading international manufacturer of highly-engineered precision plain, roller and ball bearings for the industrial, defense and aerospace industries,

**************************************************************

RBC Bearings Inc. (Nasdaq:ROLL) announced the establishment of a new $150 million 5-year senior secured revolving credit facility. The new facility replaces the existing facility which would have expired in June 2011. Terms of the facility include a $150 million revolver with an accordion option to borrow an additional $100 million under certain circumstances and with additional commitments from lenders. The facility pricing is grid based, with an initial interest rate for borrowings under the facility of LIBOR plus 150 basis points. The new credit facility will be used to fund working capital and potential acquisitions.

RBC Bearings Incorporated manufactures and markets engineered precision plain, roller, and ball bearings.

**************************************************************

MusclePharm(R) Corporation (OTCBB:MSLP.OB), one of the fastest growing nutritional supplement companies in the United States, is pleased to announced a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.

The partnership begins in 2011 and MusclePharm will work closely with the WBFF and its President and CEO, Paul Dillett, who is widely considered one of the greatest bodybuilders in the sport’s history. Dillett, recognized as Canada’s greatest bodybuilder, won numerous bodybuilding titles throughout his illustrious career, and is often regarded as having one of the sport’s most recognizable physiques.

MSLP ’s award-winning products — Assault, Battle Fuel, Bullet Proof, Combat Powder, Recon and Shred Matrix — are also available online at gnc.com, bodybuilding.com, amazon.com and many other locations.

MSLP’s top management has extensive experience in the sports world and has harnessed this drive and focus into building a business to benefit its customers and help Fuel The Athlete Inside. Headquartered in Aurora, Colorado, the company is a fast-growing developer and manufacturer of safe, scientifically approved, nutritional supplements that are free of banned substances and tested by athletes. They are designed to help athletes, bodybuilders, weightlifters and fitness enthusiasts improve their performance. Each and every MusclePharm product is the end result of an advanced six-stage research and testing protocol involving the expertise of top nutrition scientists.

More about MSLP at: www.musclepharm.com

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from Global Hunter Corp. (TSX Venture Exchange (TSX.V:BOB) and the Frankfurt Stock Exchange (FSE:G5D)) for 30 (thirty) days of advertising, as well as for assistance in becoming a fully reporting publicly trading Bulletin Board company. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB).

___

Republic First Bancorp Inc. (Nasdaq:FRBK) announced Donald Reardon as the Senior Vice President/ Director of Cash Management. Don brings a wealth of knowledge and experience to Republic Bank, having previously been the Vice President of Cash Management Product and Operations Manager at TD Bank (formerly Commerce Bank). Don’s expertise and dedication to Customer Service resulted in major developments in Cash Management products and services, as well as the highest levels of Customer satisfaction.

Republic First Bancorp, Inc. operates as the holding company for Republic First Bank that provides various commercial and consumer banking products and services for individuals, small and medium-sized businesses, executives, professionals, and professional organizations in the Greater Philadelphia and Delaware area.

*********************

Majestic Gold Corp. (TSX.V:MJS)

Majestic Gold Corp. is pleased to announce the results of an updated resource estimate on its Song Jiagou Mine.

The most significant changes from the previous estimate are:

• Increase in Indicated tonnes by 35.34% to 33,739,586 tonnes
• Increase in Indicated contained gold by 24.09% to 1,244,211 ounces
• Increase in Inferred tonnes by 37.96% to 38,812,054 tonnes
• Increase in Inferred contained gold by 7.48% to 1,830,576 ounces

Majestic Gold Corp. engages in the exploration and development of mineral properties in China. Majestic focuses on its gold project located in the prolific gold region of Song Jiagou in eastern Shandong Province. Majestic is headquartered in Vancouver, Canada.

To learn more about Majestic visit: http://www.majesticgold.net

*********************

MusclePharm Corporation (MSLP.OB)

MusclePharm Corporation is pleased to announced a multi-year partnership with the World Bodybuilding and Fitness Federation (WBFF) that will place the company as the title sponsor of the World Famous WBFF through 2014.

The partnership begins in 2011 and MSLP will work closely with the WBFF and its President and CEO, Paul Dillett, who is widely considered one of the greatest bodybuilders in the sport’s history. Dillett, recognized as Canada’s greatest bodybuilder, won numerous bodybuilding titles throughout his illustrious career, and is often regarded as having one of the sport’s most recognizable physiques.

About MusclePharm

Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved, nutritional supplements that are 100% free of any banned substances. Based on years of research, MSLP products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. MSLP’s propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MSLP is sold in over 120 countries and available in over 5,000 US retail outlets that include GNC, and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.

To learn more about MSLP visit: http://www.musclepharm.com

*********************

Simulations Plus Inc. (Nasdaq:SLP) a leading provider of software for pharmaceutical discovery and development, reported its financial results for its 2010 fiscal year (FY10) and fourth quarter (4Q10) ended August 31, 2010. Ms. Momoko Beran, chief financial officer for Simulations Plus, said: “We’re very pleased to report these results, completing a fiscal year with every quarter setting a new quarterly record, resulting in a record fiscal year. We continue to experience strong demand for our pharmaceutical business products and services. The introduction of our new EyeProTM eyegaze system at the end of the third quarter contributed to greatly improved results in the fourth quarter for our Words+ subsidiary, earning just over $137,000 compared to a loss of $10,000 in last year’s fourth quarter. We have also seen considerable improvement in collection of aged accounts receivable for the Words+ subsidiary since we implemented new electronic billing and tracking software in October 2009, resulting in a reduced allowance for bad debts compared to previous years. We are using some of our cash to repurchase and retire shares, resulting in lower dilution and better per-share metrics for our shareholders. So far this year, we have repurchased over 700,000 shares of the one million authorized by the board of directors from February 15, 2010 to February 15, 2011. It is our intention to continue to repurchase at times and prices deemed prudent by management; however, we do not announce when we may do so nor at what prices.”

Simulations Plus, Inc. develops and produces software for use in pharmaceutical research and education, as well as provides contract research services to the pharmaceutical industry. Its software products include ADMET Predictor, a program that enables pharmaceutical researchers to estimate absorption, distribution, metabolism, excretion, and toxicity properties of various chemical compounds from their molecular structure; ADMET Modeler, a program that automates the generation of predictive models used in ADMET Predictor; ClassPharmer, a software for screening data analysis, hit-to-lead development, and lead optimization; DDDPlus, a tool that simulates the in vitro disintegration and dissolution of dosage forms in USP Paddle, Basket, and Flow-Through experiments; and GastroPlus, a software program that simulates the dissolution and absorption of a drug in the human gastrointestinal tract.

*********************

LightPath Technologies Inc. (Nasdaq:LPTH) a global manufacturer, distributor and integrator of patented optical components and assemblies, announced that it has expanded its direct selling channels in China as part of its strategy to deliver high volumes of aspheric lenses to Asian manufacturers of optical equipment. LightPath Optical Instrumentation Co., Ltd., the Company’s wholly-owned Shanghai-based subsidiary, has added an experienced sales engineer to its staff. In addition, the Company has signed two new distributors to create more comprehensive market coverage in China. Daheng New Epoch Technology (www.dhxjy.com.cn) and Diqin Tech Science and Technology (www.diqintech.com), both based in China, provide LightPath with new, valuable selling channels to capitalize on increased demand from Chinese manufacturers. Jim Gaynor, CEO of LightPath, commented, “LightPath continues to successfully execute a growth strategy that addresses high volume markets in Asia, Europe and the Americas. Our agreements with Diqin Tech Science and Technology and Daheng New Epoch Technology give LightPath significantly expanded exposure throughout China. When combined with our recently expanded distribution agreement with AMS Technologies in Europe, and WPG in the Americas and South Asia, LightPath has dramatically broadened our sales channels around the world.”

LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies in the United States, Europe, North Africa, and Asia. It offers precision molded glass aspheric optics, precision molded infrared molder optics, isolators, proprietary fiber-optic collimators, GRADIUM glass lenses, and other optical materials used to produce products that manipulate light.

___

****************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty-five thousand dollars in cash from a third party for (thirty) days of advertising for Majestic Gold Corp, TSX Venture Exchange (TSX.V:MJS) and the Frankfurt Stock Exchange (FSE:MJT). Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB).

********************************************************************

CRWEnewswire is not liable for the contents of this news, as well as not being liable for any errors or delays in the content, or for any actions taken in reliance thereon.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (MSLP.OB)